Journal of the American Academy of Dermatology
Издатель: Elsevier · ISSN 0190-9622 · 80 статей
-
Re: Comparative and complementary diagnostic value of dermatoscopy and clinical close-up photography in skin cancer diagnosis: A study from the MILK10k dataset
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Hafiza Syeda Bisha, F.N.U. Tooba, Muhammad Hassan Saeed
-
Response to Bisha et al., “Re: Comparative and complementary diagnostic value of dermatoscopy and clinical close-up photography in skin cancer diagnosis: A study from the MILK10k dataset”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Christoph Müller, Harald Kittler
-
Response to Du et al, “Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Emily G. Summers, Hans Herfarth, Christina Crater, Delphine Deherder, Christopher J. Sayed
-
Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Wei Du, Honglin Chen
-
Response to Wang et al, “Cartilage grafts for alar reconstruction in nasolabial interpolation flap surgery may negatively affect breathing function and cosmesis: A retrospective study”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Chandler W. Rundle, Tess M. Lukowiak, Ian A. Maher
-
Accredited compounding pharmacies: A complementary approach to injectable triamcinolone acetonide shortages
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Aaron D. Smith, Gabrielle Schwartzman, Alexandra W. Hickman
-
Response to Smith et al, “Accredited compounding pharmacies: A complementary approach to injectable triamcinolone acetonide shortages”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Jia Qi Adam Bai, Eric McMullen, Cathryn Sibbald, Jeffrey Donovan
-
Response to the letter by Ghanim et al, “Comment on Gao et al’s ‘A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis’”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Yuling Shi
-
Comment on Gao et al’s “A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Dina Ghanim, Michael Ghebrial, Chiara Tognaccini, Leah E. Thomas, Zahra Ansari, Khushi Gupta, Jashin J. Wu
-
Hispanic ethnicity does not influence the relationship between obesity with atopic dermatitis: Response to Letter regarding Hispanic ethnicity as a covariate
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Ladonya Jackson-Cowan, Gil Yosipovitch
-
Hispanic ethnicity as an unconsidered variable in the obesity‑atopic dermatitis relationship
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Aaron D. Smith, Nicole Edmonds, Christian L. Carr
-
Response to Guan et al, “Letter to the Editor ‘Rethinking routine cartilage grafting for alar defects’”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Stephanie Y. Wang, Emily R. Hunter, Karla L. Valdes Morales, Nikhita J. Perry, Eli Feldman, Joseph F. Sobanko, Jeremy...
-
Rethinking routine cartilage grafting for alar defects
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Zihe Guan, Jiaqi Fu, Yingting Fu, Yang Liu
-
Methodologic considerations and real-world challenges in evaluating the long-term efficacy of 5-fluorouracil for Bowen's disease: A response to Moermans et al
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Xin Zhao
-
Response to Zhao, “Methodologic considerations and real-world challenges in evaluating the long-term efficacy of 5-fluorouracil for Bowen disease: A response to Moermans et al”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Myrthe M.G. Moermans, Patty J. Nelemans, Klara Mosterd
-
Considerations on the relation between Medicaid expansion and overall survival in patients with resected Merkel cell carcinoma
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Mia I. Fuentes, Tejas P. Joshi
-
Response to Fuentes and Joshi, “Considerations on the relation between Medicaid expansion and overall survival in patients with resected Merkel cell carcinoma”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Yingjoy Li, Thuy B. Tran
-
Response to Jean et al, “Alopecia after glucagon-like peptide-1 agonist therapy: A TriNetX Database active comparator retrospective cohort study”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Kyle C. Lauck, Areeba Ahmed, Stanislav N. Tolkachjov
-
Methodological concerns regarding “Alopecia after GLP-1 agonist therapy: A TriNetX database active comparator retrospective cohort study”
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Shio-Shin Jean, Chih-Cheng Lai
-
December 2026 iotaderma (#394)
Publication date: December 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 6 Author(s): Robert I. Rudolph
-
Response to Wu et al “Clinical Potential of Antimicrobial Photodynamic Therapy”
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Xinyao Liu, Wenjie Fang, Yuping Ran
-
Clinical potential of antimicrobial photodynamic therapy
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Gujie Wu, Lanmei Lin, Lee Sheung, Chia-Kang Ho, Juan Du
-
Correspondence to Abdel Azim et al, “Sunscreens part 2: Regulation and safety”. Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Christine Pak, Molly Nguyen, Darya Asoudegi, Maria Tsoukas
-
Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Brandon L. Adler
-
Response to van Rooij, “Clinical context and comparative interpretation of dermatologic disease burden in people with HIV in the modern antiretroviral era”
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Yagiz Matthew Akiska, Natella Rakhmanina, Adam Friedman
-
Response to Akiska et al., “Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC”
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Nicholas van Rooij
-
Response to Guo et al, “Response to Huang et al’s ‘Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the Chinese Rheumatism Data Center (CRDC)’”
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Lu Yuan, Haochen Huang, Min Hui, Shihan Xu, Dong Xu
-
Response to Huang et al, “Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the CRDC”
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Baocheng Guo, Xiaoyu Zhang
-
Photodynamic therapy for onychomycosis: Interpreting current evidence
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Nuran C. Golbasi, Shari R. Lipner
-
Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic disease-modifying antirheumatic drugs in psoriasis and psoriatic arthritis: A 15-year multicenter cohort study
Publication date: November 2026 Source: Journal of the American Academy of Dermatology, Volume 95, Issue 5 Author(s): Yingying Xue